PetMed Express To Announce Its Second Quarter Financial Results on October 25, 2021
18 Outubro 2021 - 09:00AM
PetMed Express, Inc. (NASDAQ: PETS) will announce its financial
results for the quarter ended September 30, 2021 on Monday, October
25, 2021 at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time,
the Company will host a conference call to review the financial
results.
To access the call, which is open to the public,
please dial (877) 407-0789 (toll free) or (201) 689-8562, ten
minutes prior to the scheduled start time, and all callers will be
placed on hold until the call begins at 4:30 P.M Eastern Time. We
will also provide a link at
https://www.1800petmeds.com/investor.html for those who wish
to stream the call via webcast.
For those unable to participate in the live
event, the call will be available for replay from 7:30 P.M. Eastern
Time on October 25, 2021 until November 8, 2021 at 11:59 P.M.
Eastern Time. To access the replay, call (844) 512-2921 (toll free)
or (412) 317-6671, and enter passcode 13724036.
Founded in 1996, PetMed Express is America’s
Most Trusted Pet Pharmacy, delivering prescription and
non-prescription pet medications and other health products for
dogs, cats, and horse at competitive prices direct to the consumer
through its 1-800-PetMeds toll free number and on the Internet
through its website at www.petmeds.com.
This press release may contain “forward-looking”
statements, as defined in the Private Securities Litigation Reform
Act of 1995 or by the Securities and Exchange Commission, that
involve a number of risks and uncertainties, including the
Company’s ability to meet the objectives included in its business
plan. Important factors that could cause results to differ
materially from those indicated by such “forward-looking”
statements are set forth in Management’s Discussion and Analysis of
Financial Condition and Results of Operations in the PetMed Express
Annual Report on Form 10-K for the year ended March 31, 2021. The
Company’s future results may also be impacted by other risk factors
listed from time to time in its SEC filings, including, but not
limited to, the Company's Form 10-Q and its Annual Report on Form
10-K.
For investment relations contact PetMed Express,
Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024